BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24510996)

  • 1. The cytoplasmic extension of the integrin β6 subunit regulates epithelial-to-mesenchymal transition.
    Lee C; Lee C; Lee S; Siu A; Ramos DM
    Anticancer Res; 2014 Feb; 34(2):659-64. PubMed ID: 24510996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alphavbeta6-Fyn signaling promotes oral cancer progression.
    Li X; Yang Y; Hu Y; Dang D; Regezi J; Schmidt BL; Atakilit A; Chen B; Ellis D; Ramos DM
    J Biol Chem; 2003 Oct; 278(43):41646-53. PubMed ID: 12917446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the integrin alpha v beta6 in regulating the epithelial to mesenchymal transition in oral cancer.
    Ramos DM; Dang D; Sadler S
    Anticancer Res; 2009 Jan; 29(1):125-30. PubMed ID: 19331141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasin (S100A7) associates with integrin β6 subunit and is required for αvβ6-dependent carcinoma cell invasion.
    Morgan MR; Jazayeri M; Ramsay AG; Thomas GJ; Boulanger MJ; Hart IR; Marshall JF
    Oncogene; 2011 Mar; 30(12):1422-35. PubMed ID: 21132011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the beta6 integrin subunit.
    Niu J; Dorahy DJ; Gu X; Scott RJ; Draganic B; Ahmed N; Agrez MV
    Int J Cancer; 2002 Jun; 99(4):529-37. PubMed ID: 11992542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrins alpha5beta1, alphavbeta1, and alphavbeta6 collaborate in squamous carcinoma cell spreading and migration on fibronectin.
    Koivisto L; Grenman R; Heino J; Larjava H
    Exp Cell Res; 2000 Feb; 255(1):10-7. PubMed ID: 10666329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HS1-associated protein X-1 regulates carcinoma cell migration and invasion via clathrin-mediated endocytosis of integrin alphavbeta6.
    Ramsay AG; Keppler MD; Jazayeri M; Thomas GJ; Parsons M; Violette S; Weinreb P; Hart IR; Marshall JF
    Cancer Res; 2007 Jun; 67(11):5275-84. PubMed ID: 17545607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop.
    Yang H; Wen L; Wen M; Liu T; Zhao L; Wu B; Yun Y; Liu W; Wang H; Wang Y; Wen N
    Anticancer Drugs; 2018 Mar; 29(3):216-226. PubMed ID: 29360662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. αv integrin processing interferes with the cross-talk between αvβ5/β6 and α2β1 integrins.
    Defilles C; Montero MP; Lissitzky JC; Rome S; Siret C; Luis J; André F; Rigot V
    Biol Cell; 2011 Nov; 103(11):519-29. PubMed ID: 21787362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
    Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS
    Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal-adhesion-independent integrin-αv regulation of FAK and c-Myc is necessary for 3D skin formation and tumor invasion.
    Duperret EK; Dahal A; Ridky TW
    J Cell Sci; 2015 Nov; 128(21):3997-4013. PubMed ID: 26359297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFbeta1 activates c-Jun and Erk1 via alphaVbeta6 integrin.
    Luettich K; Schmidt C
    Mol Cancer; 2003 Sep; 2():33. PubMed ID: 14572313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruitment of focal adhesion kinase and paxillin to beta1 integrin promotes cancer cell migration via mitogen activated protein kinase activation.
    Crowe DL; Ohannessian A
    BMC Cancer; 2004 May; 4():18. PubMed ID: 15132756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 Promotes Epithelial-Mesenchymal Transition and Cell Invasion through Integrin
    Sun Q; Shang Y; Sun F; Dong X; Niu J; Li F
    Oxid Med Cell Longev; 2020; 2020():8032187. PubMed ID: 32855767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct integrin alphavbeta6-ERK binding: implications for tumour growth.
    Ahmed N; Niu J; Dorahy DJ; Gu X; Andrews S; Meldrum CJ; Scott RJ; Baker MS; Macreadie IG; Agrez MV
    Oncogene; 2002 Feb; 21(9):1370-80. PubMed ID: 11857080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition.
    Sakamoto T; Kawano S; Matsubara R; Goto Y; Jinno T; Maruse Y; Kaneko N; Hashiguchi Y; Hattori T; Tanaka S; Kitamura R; Kiyoshima T; Nakamura S
    Oral Oncol; 2017 Jun; 69():15-25. PubMed ID: 28559016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the interaction between heterodimeric αvβ6 integrin and urokinase plasminogen activator receptor (uPAR) using functional proteomics.
    Ahn SB; Mohamedali A; Anand S; Cheruku HR; Birch D; Sowmya G; Cantor D; Ranganathan S; Inglis DW; Frank R; Agrez M; Nice EC; Baker MS
    J Proteome Res; 2014 Dec; 13(12):5956-64. PubMed ID: 25318615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scutellarin inhibits the growth and invasion of human tongue squamous carcinoma through the inhibition of matrix metalloproteinase-2 and -9 and αvβ6 integrin.
    Li H; Huang D; Gao Z; Chen Y; Zhang L; Zheng J
    Int J Oncol; 2013 May; 42(5):1674-81. PubMed ID: 23546449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nestin regulates prostate cancer cell invasion by influencing the localisation and functions of FAK and integrins.
    Hyder CL; Lazaro G; Pylvänäinen JW; Roberts MW; Qvarnström SM; Eriksson JE
    J Cell Sci; 2014 May; 127(Pt 10):2161-73. PubMed ID: 24610946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of aquaporin 3 on growth of human esophageal and oral squamous cell carcinoma.
    Kusayama M; Wada K; Nagata M; Ishimoto S; Takahashi H; Yoneda M; Nakajima A; Okura M; Kogo M; Kamisaki Y
    Cancer Sci; 2011 Jun; 102(6):1128-36. PubMed ID: 21401805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.